19 de Noviembre del 2019
Updated: 11/18/19
On November 14, 2019, Avkare Pharmaceuticals issued a voluntary recall of its ranitidine medications due to an elevated amount of an unexpected impurity (NDMA) found in the active pharmaceutical ingredient.
Express Scripts will send a letter to patients who have received medication impacted by the recall.
The FDA recommends speaking with your prescriber if you want to stop your medication or use an alternative medication.
|
Description |
Lot # /Exp Date |
NDC |
|
RANITID TAB 150MG AVK 1000 |
HH04918A 08/31/20; HG02319A 06/30/21; HG02419A 06/30/21; HG02619A 06/30/21; HH04518A 08/31/20; HH04618A 08/31/20; HL07518A 11/30/20; HH04818A 08/31/20; HE03319A 04/30/21; HK006918A 10/31/20; HK02718A 10/31/20; HK16617A 11/30/19; HL03917A 11/30/19; HL04017A 11/30/19; HA00419A 12/31/20; HH04718A 08/31/20; HC14018A 04/30/20; HA00519A 12/31/20; HA2719A 12/31/20; HA02819A 12/31/20; HB03518A 03/31/20; HB03618A 03/31/20; HC05019A 03/31/21; HE05419A 04/30/21; HC05911A 03/31/21; HE03419A 04/30/21; HC14118A 04/30/20; HC14218A 04/30/20; HC14318A 04/30/20; HC14418A 04/30/20; HC14518A 05/31/20; HM06017A 11/30/19; HC05119A 03/31/21; HM06117A 11/30/19; HL07418A 11/30/20; |
42291072410 |
|
RANITID TAB 150MG AVK 180 |
21570 03/01/20; 21571 03/01/20; 22190 03/31/20; 22192 05/31/20; 22497 05/31/20; 22620 05/31/20; 22999 09/30/20; 23000 09/30/20; 24158 03/31/21; 24159 04/30/21 |
42291072418 |
|
RANITID TAB 150MG AVK 60 |
22657 03/31/20; 24157 04/30/21; 23001 09/30/20; 22193 03/31/20; 21680 03/01/20; 21241 03/01/20; 23002 09/30/20 |
42291072460 |
|
RANITID TAB 300MG AVK 250 |
22247 06/30/20; 24289 01/31/21; 24199 01/31/21; 24198 01/31/21; 23244 11/30/20; 23214 09/30/20; 21528 02/01/20; 21527 02/01/20; 21309 02/01/20; 21307 02/01/20; 23243 09/30/20 |
42291072525 |
|
RANITID TAB 300MG AVK 30 |
23776 01/31/21; 22291 06/30/20; 23215 09/30/20 |
42291072530 |
Última actualización: 08 de Diciembre del 2023